FALCON POINT CAPITAL, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
FALCON POINT CAPITAL, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$321,000
-36.3%
2,871
-58.5%
1.57%
+44.0%
Q1 2020$504,000
-40.4%
6,925
-14.7%
1.09%
+1.4%
Q4 2019$846,000
-76.3%
8,115
-75.3%
1.08%
-45.0%
Q3 2019$3,572,000
+0.5%
32,826
+5.4%
1.96%
+2.4%
Q2 2019$3,554,000
-7.3%
31,132
+2.1%
1.91%
-8.5%
Q1 2019$3,835,000
+18.5%
30,505
+27.9%
2.09%
+8.0%
Q4 2018$3,237,000
-73.2%
23,851
-45.7%
1.94%
-25.3%
Q3 2018$12,059,000
+2.6%
43,933
-22.6%
2.59%
+12.2%
Q2 2018$11,756,000
-11.5%
56,747
-29.5%
2.31%
-13.1%
Q1 2018$13,290,000
+0.7%
80,468
-16.6%
2.66%
+19.4%
Q4 2017$13,204,000
-21.4%
96,429
-16.6%
2.23%
-8.8%
Q3 2017$16,802,000
+14.1%
115,597
-4.7%
2.44%
+22.8%
Q2 2017$14,727,000
+11.3%
121,311
-2.9%
1.99%
+12.6%
Q1 2017$13,230,000
-20.7%
124,997
-23.9%
1.76%
-21.1%
Q4 2016$16,689,000
+14.6%
164,246
+8.0%
2.24%
+0.4%
Q3 2016$14,561,000
+107.0%
152,106
+157.9%
2.23%
+83.3%
Q2 2016$7,033,000
-35.8%
58,969
-42.3%
1.22%
-35.7%
Q1 2016$10,951,000
+67.5%
102,263
+69.6%
1.89%
+33.9%
Q4 2015$6,538,000
+146.3%
60,304
+94.6%
1.41%
+48.7%
Q3 2015$2,654,00030,9910.95%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders